The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
Open accessAbstract
Mucin 1 (MUC1) is a large complex glycoprotein that is highly expressed in breast cancer, and as such could be a target for immunotherapy. In mice, human MUC1 is highly immunogenic, particularly when conjugated to mannan, where a high frequency of CD8(+) MHC-restricted cytotoxic T lymphocytes is induced, accompanied by tumor protection. On this basis, a clinical trial was performed in which 25 patients with advanced metastatic carcinoma of breast, colon, stomach, or rectum received mannan-MUC1 in increasing doses. After 4 to 8 injections, large amounts of IgG1 anti-MUC1 antibodies were produced in 13 out of 25 patients (with antibody titers by ELISA of 1/320-1/20,480). Most of the antibodies reacted to the epitopes STAPPAHG and PAPGSTAP. In addition, T cell proliferation was found in 4 out of 15 patients, and CTL responses were seen in 2 out of 10 patients. Mannan-MUC1 can immunize patients, particularly for antibody formation, and to a lesser extent, cellular responses. It remains to be seen whether such responses have antitumor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Karlsson, R., Michaelsson, A., & Mattsson, L. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90331-9 · Cited by 1,077
Gendler, S. J., & Spicer, A. P. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003135 · Cited by 979
Strategies for epitope analysis using peptide synthesis
Geysen, H. M., Rodda, S. J., Mason, T. J., Tribbick, G., & Schoofs, P. G. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90085-8 · Cited by 868
Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.
Disis, M. L., Calenoff, E., McLaughlin, G., Murphy, A. E., Chen, W., Groner, B., Jeschke, M., Lydon, N., McGlynn, E., & Livingston, R. B. (1994) · PubMed · Cited by 524
Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer.
Itzkowitz, S., Yuan, M., Montgomery, C. K., Kjeldsen, T., Takahashi, H., Bigbee, W. L., & Kim, Y. S. (1989) · PubMed · Cited by 511
Cell membrane-associated mucins and their adhesion-modulating property
Hilkens, J., Ligtenberg, M. J. L., Vos, H. L., & Litvinov, S. V. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90315-z · Cited by 453
Barnd, D. L., Lan, M. S., Metzgar, R. S., & Finn, O. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7159 · Cited by 449
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3
Marchand, M., Weynants, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwuck, R., Humblet, Y., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630622 · Cited by 417
Jerome, K. R., Barnd, D. L., Bendt, K. M., Boyer, C. M., Taylor‐Papadimitriou, J., McKenzie, I. F. C., Bast, R. C., & Finn, O. J. (1991) · PubMed · Cited by 349
Self-citationTolerance, Danger and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.991 · Cited by 335
Kotera, Y., Fontenot, J. D., Pecher, G., Metzgar, R. S., & Finn, O. J. (1994) · PubMed · Cited by 311
Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.
Siddiqui, J., Abe, M., Hayes, D., Shani, E., Yunis, E., & Kufe, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2320 · Cited by 308
Gendler, S. J., Burchell, J. M., Duhig, T., Lamport, D., White, R., Parker, M., & Taylor-Papadimitriou, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6060 · Cited by 289
A Phase I Trial of a Synthetic Mucin Peptide Vaccine
Goydos, J. S., Elder, E., Whiteside, T. L., Finn, O. J., & Lotze, M. T. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0264 · Cited by 275
Houbiers, J. G. A., Nijman, H. W., Van Der Burg, S. H., Drijfhout, J. W., Kenemans, P., Van De Velde, C. J. H., Brand, A., Momburg, F., Kast, W. M., & Melief, C. J. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230905 · Cited by 258
WRESCHNER, D. H., HAREUVENI, M., TSARFATY, I., SMORODINSKY, N., HOREV, J., ZARETSKY, J., KOTKES, P., WEISS, M., LATHE, R., DION, A., et al. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15511.x · Cited by 245
Burchell, J., Taylor‐Papadimitriou, J., Boshell, M., Gendler, S., & Duhig, T. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440423 · Cited by 230
Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.
Apostolopoulos, V, Pietersz, G. A., Loveland, B. E., Sandrin, M. S., & McKenzie, I. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10128 · Cited by 189
Self-citationTopfer, F., Gordon, T., & McCluskey, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.875 · Cited by 185
MacLean, G. D., Reddish, M. A., Koganty, R. R., Wong, T. C., Gandhi, S. S., Smolenski, M., Samuel, J., Nabholtz, J. M., & Longenecker, B. M. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01740902 · Cited by 184
Jerome, K. R., Domenech, N., & Finn, O. J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1654 · Cited by 175
Ressing, M. E., van Driel, W. J., Celis, E., Sette, A., Brandt, M. P., Hartman, M., Anholts, J. D., Schreuder, G. M. T., ter Harmsel, W. B., Fleuren, G. J., et al. (1996) · PubMed · Cited by 175
Cellular Mucins: Targets for Immunotherapy
Apostolopoulos, V., & McKenzie, I. F. C. (2017) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v37.i2-6.110 · Cited by 136
Self-citationvon Mensdorff‐Pouilly, S., Gourevitch, M. M., Kenemans, P., Verstraeten, A. A., Litvinov, S. V., van Kamp, G. J., Meijer, S., Vermorken, J. B., & Hilgers, J. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00048-2 · Cited by 134
MacLean, G. D., Bowen-Yacyshyn, M. B., Samuel, J., Meikle, A., Stuart, G. C. E., Nation, J. G., Poppema, S., Jerry, M., Koganty, R. R., Wong, T. C., et al. (1992) · Journal of Immunotherapy · doi:10.1097/00002371-199205000-00008 · Cited by 121
Monoclonal antibodies reactive with mucin expressed in breast cancer
Xing, P., Tjandra, J. J., Stacker, S. A., et al. (1989) · Immunology and Cell Biology · doi:10.1038/icb.1989.29 · Cited by 110
Self-citationPolymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients
Gourevitch, M. M., von Mensdorff‐Pouilly, S., Litvinov, S. V., Kenemans, P., van Kamp, G. J., Verstraeten, A. A., & Hilgers, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.436 · Cited by 108
Cellular Mucins: Targets for Immunotherapy
Apostolopoulos, V., & McKenzie, I. F. C. (1994) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v14.i3-4.40 · Cited by 108
Self-citationGendler, S. (1995) · Annual Review of Physiology · doi:10.1146/annurev.physiol.57.1.607 · Cited by 84
CTL in mice immunized with human mucin 1 are MHC-restricted
Apostolopoulos, V., Loveland, B. E., Pietersz, G. A., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5089 · Cited by 64
Self-citationNatural human anti-Galα(1,3)Gal antibodies react with human mucin peptides
Sandrin, M. S., Vaughan, H. A., Xing, P., & McKenzie, I. F. C. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018521217276 · Cited by 57
Self-citationEpitope mapping of anti-breast and anti-ovarian mucin monoclonal antibodies
Pei-Xiang, X., Prenzoska, J., & McKenzie, I. F. C. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90201-8 · Cited by 41
Self-citationApostolopoulos, V., Xing, P., Trapani, J. A., et al. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.131 · Cited by 40
Self-citation
Cited by
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
Dube, D. H., & Bertozzi, C. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1751 · Cited by 1,598
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
Tacken, P. J., de Vries, I. J. M., Torensma, R., & Figdor, C. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2173 · Cited by 750
mRNA vaccine delivery using lipid nanoparticles
Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0006 · Cited by 624
Pathogen recognition and development of particulate vaccines: Does size matter?
Xiang, S. D., Scholzen, A., Minigo, G., David, C., Apostolopoulos, V., Mottram, P. L., & Plebanski, M. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.016 · Cited by 602
Self-citation
Metadata
- Authors
- Karanikas, V, Hwang, L. A., Pearson, J., Ong, C. S., Apostolopoulos, V, Vaughan, H., Xing, P. X., Jamieson, G., Pietersz, G., Tait, B., Broadbent, R., Thynne, G., & McKenzie, I. F.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-12-01
- Volume
- 100
- Issue
- 11
- Pages
- 2783-2792
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2014733698
- Cited by
- 263
- References
- 37
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.